Recurrent mutations of metabolism-regulating genes, such as VHL, PTEN, MTOR, PI3CA and TSC1/2, and broader epigenetic and post-translational dysregulation of components of various metabolic pathways lead to the concept that ccRCC is a metabolic disease2,3. Here, VHL is linked to nonpapillary renal cell carcinoma.